Parenteral Formula Market to Reach US$ 12.5 Billion by 2034 Amid Rising Prevalence of Cancer, AIDS, and Diabetes
NEWARK, Del., March 27, 2024 /PRNewswire/ -- Look out for a growing market in Parenteral Formulas (delivered intravenously for nutrition) FMI predicts a surge due to rising malnutrition and preterm births worldwide (2024-2034). The report offers a comprehensive analysis to help you...
Source: PRWeb: Medical Pharmaceuticals - Category: Pharmaceuticals Tags: MRR Source Type: news
More News: Cancer | Cancer & Oncology | Diabetes | Endocrinology | HIV AIDS | Nutrition | Parenteral Nutrition | Pharmaceuticals